Morgan Stanley’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.42M | Sell |
|
|||||
|
2018
Q2 | $4.38M | Buy |
|
|||||
|
2018
Q1 | $1.61M | Buy |
|
|||||
|
2017
Q4 | $1.7M | Sell |
|
|||||
|
2017
Q3 | $3.17M | Buy |
|
|||||
|
2017
Q2 | $2.65M | Sell |
|
|||||
|
2017
Q1 | $2.66M | Sell |
|
|||||
|
2016
Q4 | $2.68M | Buy |
|
|||||
|
2016
Q3 | $821K | Sell |
|
|||||
|
2016
Q2 | $1.57M | Buy |
|
|||||
|
2016
Q1 | $550K | Sell |
|
|||||
|
2015
Q4 | $854K | Buy |
|
|||||
|
2015
Q3 | $536K | Sell |
|
|||||
|
2015
Q2 | $1.92M | Buy |
|
|||||
|
2015
Q1 | $2.38M | Sell |
|
|||||
|
2014
Q4 | $3.86M | Sell |
|
|||||
|
2014
Q3 | $6.03M | Buy |
|
|||||
|
2014
Q2 | $3.47M | Buy |
|
|||||
|
2014
Q1 | $3.08M | Buy |
|
|||||
|
2013
Q4 | $1.71M | Buy |
|
|||||
|
2013
Q3 | $1.26M | Sell |
|
|||||
|
2013
Q2 | $1.01M | Buy |
|